MedWatch

Nuevolution hopes to be ready for early clinical trials in 2019

The biotech company Nuevolution will soon take its first projects to the clinic. Two drugs may be ready for clinical trials in 2019, says CEO Alex Haarh Gouliaev.

Alex Haahr Gouliaev, CEO in Nuevolution. | Foto: Nuevolution

The biotech company Nuevolution is preparing to step onto a larger stage and take its first drugs to the clinic, according to the company’s CEO, Alex Haarh Gouliaev.

“We have the opportunity to be ready with the first program for clinical development in the first half of 2019, if everything goes well and according to plan” says Gouliaev.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier